Open an account

JATT II Acquisition

JATT · NASDAQ

$10.33+$0.0272 (+0.26%)TodayMarket closed ·
Prev close $10.30

About JATT

JATT II Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Westfield, New Jersey. The company went IPO on 2026-04-17. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The firm is not engaged in any business operations and has not generated any revenue.

Employees
0
Headquarters
Westfield, New Jersey
Listed
Apr 17, 2026
Sector
N/A
Industry
N/A
Website
jattacquisition.com

JATT key statistics

Market cap
80.55M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
13.28K
Volume
2.71K
Open price
$10.30
High today
$10.33
Low today
$10.30
52 Week high
$23.76
52 Week low
$9.99

JATT II Acquisition (JATT) at a glance

JATT II Acquisition (JATT) last traded at $10.33, with a market cap of 80.55M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $10.30 and $10.33. The current price is 0.3% above the day's low and 0.0% below its high.

Volume so far is 2.71K shares, below the average of 13.28K shares a day.

Over the past year JATT II Acquisition has ranged from $9.99 to $23.76, and now sits 2% of the way up that range.

JATT news

  • Press releasePRNewswire

    Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.